IP Verse

Topical Antifungal Composition For Treating Onychomycosis - EP2953621

The patent EP2953621 was granted to Polichem on May 1, 2019. The application was originally filed on Jan 23, 2014 under application number EP14701713A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2953621

POLICHEM
Application Number
EP14701713A
Filing Date
Jan 23, 2014
Status
Opposition Rejected
Nov 5, 2021
Grant Date
May 1, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WILSON GUNNJan 28, 2020WILSON GUNNADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0515312
DESCRIPTIONUS2008261986
DESCRIPTIONUS2012128612
DESCRIPTIONUS5681849
DESCRIPTIONUS7462362
DESCRIPTIONWO0207683
DESCRIPTIONWO0211764
INTERNATIONAL-SEARCH-REPORTUS6319509
INTERNATIONAL-SEARCH-REPORTUS6455592
INTERNATIONAL-SEARCH-REPORTUS7462362
INTERNATIONAL-SEARCH-REPORTWO0207683
OPPOSITIONUS2004057919
OPPOSITIONUS7820720
OPPOSITIONWO0207683
OPPOSITIONWO2008098634
OPPOSITIONWO2010138674

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- AJIT C; SUVANNASANKHA A; ZAERI N; MUNOZ SJ, "Terbinafine-associated hepatotoxicity", AM J MED SCI., (2003), vol. 325, pages 292 - 5-
DESCRIPTION- Onychomycosis - the current approach to diagnosis and therapy, MARTIN DUNITZ, (1999), pages 6 - 9-
DESCRIPTION- SLORDAL L; SPIGSET 0, "Heart failure induced by non-cardiac drugs", DRUG SAF., (2006), vol. 29, pages 567 - 86-
DESCRIPTION- TOSTI A; HAY R; ARENAS-GUZMAN R, "Patients at risk of onychomycosis - risk factor identification and active prevention", J EUR ACAD DERMATOL VENEOROL, (2005), vol. 19, pages 13 - 16-
DESCRIPTION- BARAN R; TOSTI A; HARTMANE I ET AL., "An innovative water soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis", J EUR ACAD DERMATOL VENEOROL, (2009), vol. 23, doi:doi:10.1111/j.1468-3083.2009.03164.x, pages 773 - 781, XP055113869
INTERNATIONAL-SEARCH-REPORT- GUPTA A, "Terbinafine nail solution in onychomycosis patients: Terbinafine pharmacokinetic profile and initial clinical efficacy and safety", JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY, INC, US, vol. 60, no. 3, ISSN 0190-9622, (200903), page AB113, (20090224), XP025964326 [Y] 1-27 * abstract *-
INTERNATIONAL-SEARCH-REPORT- GHANNOUM MAHMOUD A. ET AL, "Determination of the efficacy of terbinafine hydrochloride nail solution in the topical treatment of dermatophytosis in a guinea pig model", MYCOSES, (200901), vol. 52, no. 1, doi:10.1111/j.1439-0507.2008.01540.x, ISSN 0933-7407, pages 35 - 43, XP055114111 [A] 1-27 * abstract * * page 37, column 2, paragraph 2 *
INTERNATIONAL-SEARCH-REPORT- ELEWSKI B E ET AL, "Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.", JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY : JEADV MAR 2013, (201303), vol. 27, no. 3, doi:10.1111/j.1468-3083.2011.04373.x, ISSN 0926-9959, pages 287 - 294, XP055114091 [YD] 1-27 * abstract * * page 288, column 1, paragraph 3 * * figure 1 * * table 2 *
INTERNATIONAL-SEARCH-REPORT- SHEMER A, "Update: medical treatment of onychomycosis", DERMATOLOGIC THERAPY, (201211), vol. 25, no. 6, doi:10.1111/j.1529-8019.2012.01551.x, ISSN 1396-0296, pages 582 - 593, XP055114094 [Y] 1-27 * page 591, column 2, paragraph 3 - page 592, column 2, paragraph 1 *
OPPOSITION- Anonymus, "Loceryl (RTM) Nail Lacquer treatment leaflet", MIMS/myDr, (20120901), XP055676667-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents